Background: Mast cells have been regarded as a potential source of cytokines. Although the human mast cell line HMC–1 and human lung mast cells have been shown to produce interleukin (IL) 13, it still remains uncertain whether cord–blood–derived human cultured mast cells produce IL–13. Methods: Human cultured mast cells were raised from cord blood cells in the presence of stem cell factor (SCF) and IL–6. Levels of IL–13 mRNA were examined by a semiquantitative reverse transcriptase–polymerase chain reaction. IL–13 levels in the supernatants were measured with an enzyme–linked immunosorbent assay. Results: When the IgE–sensitized cultured mast cells were activated with anti–IgE, mRNA for IL–13 was amplified with a peak at 3 h after the stimulation. IL–13 was not detected in the supernatants of the activated mast cells in the absence of SCF, whereas the mast cells secreted significant amounts of IL–13 after the stimulation in the presence of SCF. Calcium ionophore A23187 also stimulated the mast cells to release IL–13 into the supernatant in the presence of SCF. Conclusions: These observations suggest that human mast cells can produce IL–13 under the condition with SCF. The cord–blood–derived human cultured mast cells will help in studying the functional properties of human mast cells in allergic diseases.
Correspondence to: Dr. Motohiro Kurosawa
Department of Geriatric Medicine
Hirosaki University School of Medicine
5 Zaifu–cho, Hirosaki 036–8562 (Japan)
Tel. +81 172 33 5111, Fax +81 172 39 5346, E–Mail email@example.com–u.ac.jp
Received: Received: September 29, 1998
Accepted after revision: November 26, 1998
Number of Print Pages : 5
Number of Figures : 2, Number of Tables : 0, Number of References : 20
International Archives of Allergy and Immunology
Vol. 119, No. 2, Year 1999 (Cover Date: June 1999)
Journal Editor: D. Kraft, Vienna
ISSN: 1018–2438 (print), 1423–0097 (Online)
For additional information:http://www.karger.com/journals/iaa
Article / Publication Details
Published online: 7/14/2009
Issue release date: June 1999
Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 0
ISSN: 1018-2438 (Print)
eISSN: 1423-0097 (Online)
For additional information: http://www.karger.com/IAA
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.